Charlie Marvalim

580 citations
8 papers · 383 indexed · 1 hit paper · h-index 6
Topics
Glioma Diagnosis and Treatment (2 papers)Endoplasmic Reticulum Stress and Disease (2 papers)Cancer Genomics and Diagnostics (2 papers)
Partner nations
SingaporeUnited States

In The Last Decade

Charlie Marvalim

8 papers receiving 381 citations

Hit Papers

Role of p53 in breast cancer progression: An insight into...20232026202420252023255075100

Peers

Charlie Marvalim
Comparison fields: 5 of 74
  • Molecular Biology 237
  • Cancer Research 70
  • Epidemiology 67
  • Oncology 58
  • Cell Biology 50
Replace Anindya Roy Chowdhury with:
Anindya Roy Chowdhury India
Srividya Velagapudi Switzerland
So Masaki Japan
Lucía Barbier‐Torres United States
Young Mi Song South Korea
Luca Di Leo Italy
Cameron World United States
Hyelin Na South Korea
Zhijia Li China
Maya Z. Springer United States
Charlie Marvalim relative to Anindya Roy Chowdhury India Anindya Roy Chowdhury's profile →
Citations per field
00.5×2.7×
Anindya Roy Chowdhury · 1×
Citations per year

Countries citing papers authored by Charlie Marvalim

Since Specialization
Citations

This map shows the geographic impact of Charlie Marvalim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charlie Marvalim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charlie Marvalim more than expected).

Fields of papers citing papers by Charlie Marvalim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charlie Marvalim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charlie Marvalim. The network helps show where Charlie Marvalim may publish in the future.

Co-authorship network of co-authors of Charlie Marvalim

This figure shows the co-authorship network connecting the top 25 collaborators of Charlie Marvalim. A scholar is included among the top collaborators of Charlie Marvalim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charlie Marvalim. Charlie Marvalim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
#WorkIndexed citations
1 7
2
Role of p53 in breast cancer progression: An insight into p53 targeted therapybreakdown →
104
3 11
4 13
5 47
6 197
7 3
8 1

About Charlie Marvalim

Charlie Marvalim is a scholar working on Cancer Research, Genetics and Biochemistry, having authored 8 papers that have together received 383 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (2 papers), Endoplasmic Reticulum Stress and Disease (2 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Biochemistry (38 citations), Cancer Research (70 citations) and Biological Psychiatry (9 citations). Charlie Marvalim has collaborated with scholars based in Singapore and United States. Frequent co-authors include Arpita Datta, Hong Sheng Cheng, Nguan Soon Tan, Soo Chin Lee, Wei Tan, Zun Siong Low, Guillaume Thibault, Peter Shyu, Susan A. Henry and William A. Prinz. Their work appears in journals such as Journal of Clinical Oncology, Scientific Reports and Journal of Cell Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026